New approaches in the treatment of parkinsonism.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000547:Amantadine / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000096:biosynthesis; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D002262:Carboxy-Lyases; D000109:Acetylcholine; D004298:Dopamine